Continued support of existing investors will fund commercialization efforts, product launch later this year Boulder, CO – Inscripta, a leading gene-editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new funding adds to the $85.5 million financing Inscripta announced in […]
Partners to Develop DNBseqTM Technology-Based Clinical Whole Genome Sequencing Solution for Diagnosis of Genetic Diseases HOUSTON and CAMBRIDGE, Mass. – AiLife Diagnostics Inc, a clinical molecular diagnostic and bioinformatics company, and BGI Americas, a leading global genomic services company, announced today that they have entered into an agreement to jointly develop and market a clinical whole genome sequencing […]
Instrument provides automated electrophoresis for labs with limited budgets SANTA CLARA, Calif. Agilent Technologies, Inc. (NYSE: A) announced today the shipping of a new instrument that offers laboratories a more affordable, low-throughput option for analyzing the quality of RNA and DNA samples. “The Agilent 4150 TapeStation system makes quality control in next-generation sequencing easier, faster, […]
Combined Workflow Provides Complete Solution for Rapid, Automated, and Highly Multiplexed Profiling of Protein and RNA Biomarkers in FFPE Samples SEATTLE and NEWCASTLE UPON TYNE, UK — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a comarketing agreement to promote and provide technical support for a research workflow […]
Porvair Sciences announces version 2.0 of its Chromatrap® ChIP-seq kit – developed to perform chromatin immunoprecipitation (ChIP) with unparalleled sensitivity. This new Chromatrap® ChIP-seq kit enables researchers to efficiently enrich chromatin, detecting binding of low abundant transcription factors and histone modifications from the smallest quantity of starting material (1000 cells or 50ng). Using proprietary bead-free […]
The newest addition to the BGI pharma solutions offers pharmaceutical companies a customized solution that has played a key role in the global clinical trials and development of the first innovative anti-ovarian cancer precision medicine. Cambridge, MA – BGI Americas today announced the launch of OseqTMHereditary Cancer Panel (HCP) to support global clinical trials of […]
Proprietary enzymatic synthesis technology produces high quality sequences up to 3000 nucleotides long PISCATAWAY, N.J. and ATLANTA — GenScript®, the world’s leading gene synthesis provider, today at the American Association for Cancer Research launched a single-stranded DNA (ssDNA) service. The new service offers researchers access to high quality, pure ssDNA for CRISPR-based gene insertion, ultimately helping to accelerate the […]
SAN DIEGO–(BUSINESS WIRE)–Mar. 29, 2019– Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit against BGI Group’s subsidiary, Latvia MGI Tech SIA, in the Düsseldorf Regional Court in Germany. The complaint alleges that BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents, infringe EP 1 530 578 B1. This patent covers […]
– Applied DNA to Receive Staged Payments Totaling $5M Over the Next Four-Months – – Agreement Calls for Annual Payment Minima that Scale from $7 Million in Year 3 to $20 Million in Year 15 – – Applied DNA Technology to Power ETCH BioTrace System to Verify Legal Cannabis and Hemp Markets Globally – STONY […]
Following earlier LabCorp strategic investment, Mission Bio single cell-sequencing technology will be used by LabCorp to support clinical trials, along with the evaluation of potential applications in clinical diagnostics and companion diagnostics development SOUTH SAN FRANCISCO, Calif. (March 28, 2019) Mission Bio, the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced that […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
